March 23, 2020
Alnylam Pharmaceuticals escaped a stock-drop suit Monday when a federal judge in Massachusetts dismissed investors' claims that the company made misleading statements about the FDA approval prospects for a drug to treat a rare disease.
May 08, 2019
A Boston federal judge on Wednesday selected a lead plaintiff represented by Bernstein Liebhard and Berman Tabacco from among four candidates who were vying to represent a putative class of Alnylam Pharmaceuticals Inc. investors who lost money after a stock drop.